(Q34567935)

3 August 2017

1 reference

title

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise (English)

1 reference

3 August 2017

1 reference

Brines M

1

1 reference

3 August 2017

Cerami A

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

31 May 2006

1 reference

3 August 2017

1 reference

3 August 2017

70

1 reference

3 August 2017

246-250

1 reference

3 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001546

3 August 2017

0 references

cites work

A quest for erythropoietin over nine decades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Localization of specific erythropoietin binding sites in defined areas of the mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin gene expression in human, monkey and murine brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Emerging biological roles for erythropoietin in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

HIF-1: an oxygen response system with special relevance to the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin regulates endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Pleiotropic renal actions of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

NMR structure of human erythropoietin and a comparison with its receptor bound conformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin mimics ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001546

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001546

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference